Milan Lukas

6PUBLICATIONS
35CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Major global burdens of diseaseInfant and child healthApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Autoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 10, 2025
The effectiveness of second- and-third-line biologics in perianal Crohn's disease-a multicenter propensity score-matched study.

Uria Shani, Monica State, Radu Bogdan Mateescu

|Mar 24, 2025
Effect of tofacitinib exposure in utero and during breastfeeding on the immune status of exposed child.

Katarina Mitrova, Marta Kostrejova, Kristyna Zdychyncova

|Oct 22, 2024
Post-Discharge Outcomes of Elderly Patients Hospitalized for Inflammatory Bowel Disease Flare Complicated by Clostridioides difficile Infection.

Idan Goren, Ortal Fallek Boldes, Tomer Boldes

|Jul 18, 2024
Serological responses to vaccination in children exposed in utero to ustekinumab or vedolizumab: cross-sectional analysis of a prospective multicentre cohort.

Katarina Mitrova, Karin Cerna, Kristyna Zdychyncova

|Nov 29, 2023
Subcutaneous Infliximab in Refractory Crohn's Disease Patients: A Possible Biobetter?

Karin Cerna, Dana Duricova, Martin Lukas

|Mar 02, 2022
A switch from originator-adalimumab to the biosimilar SB5 in patients with Crohn's disease: an analysis of two propensity score-matched cohorts.

M Lukas, M Kolar, J Reissigova

Pageof 1

Frequent Collaborators

3 joint publications

Katarina Mitrova

2 joint publications

Karin Cerna

2 joint publications

Dana Duricova

2 joint publications

Konstantinos Karmiris